Research

  • KLUYVEROMYCES MARXIANUS FRAGILIS B0399 - CHARACTERIZATION & IDENTIFICATION

    - key features and benefits:

    - Strain characterization:

    °whole genome sequencing and analysis
    °natural resistance to gastric conditions
    °natural antibiotic resistance and compatibility with a-biotic therapy
    °effective dosage and concentration


    - Development of analytical methods

  • HUMAN HEALTH AND NUTRITION

    A great network with universities and research institutes world-wide enabled Turval to focus our scientific efforts and build solid scientific research on the use of Probiotic Lactic Yeast, Kluyveromyces marxianus fragilis B0399 (TURVAL B0399) in four key health areas: gut, oral, women's and immune health.

  • NOVEL HEALTH AREAS

    We aspire to innovate industries driven by the goals of our customers around the globe. We understand their needs for flexibility and customized solutions and and try to meet them by continuous development of new solutions.

  • FOOD SCIENCE & TECHNOLOGY INNOVATION

    Nowadays probiotic delivery has been widely associated with different foods (especially dairy). However, most of the commonly used probiotic bacteria do not survive stomach acid environment unless incorporated into specific encapsulating materials that can protect them during food storage and gastrointestinal transit - the process which negatively effects a probiotic cost-effectiveness.

    Selection of the adequate gastro-resistant and shelf stable probiotic strain, such as Turval B0399, and selection of the adequate food system to deliver the probiotics, are two vital factors to be considered when developing functional, probiotic food products.

  • ANIMAL HEALTH